https://www.selleckchem.com/products/fb23-2.html
After reviewing titles and abstracts, 24 studies were considered potentially eligible, but 22 were excluded after full-text analysis. Finally, 2 studies were included. In the meta-analysis, albumin was associated to significant lower risks of persistent HE (risk ratio - RR=0.60; 95% confidence interval - CI=0.38-0.95, p=0.03) and mortality (RR=0.54; 95% CI=0.33-0.90, p=0.02). Albumin administration improves HE and reduces mortality in patients with cirrhosis and HE. Albumin administration improves HE and reduces mortality in patients wit
Like
Comment
Share
